The use of Invivofectamine reagent as a means to deliver nucleic acid to the eye for treatment of Age-Related Macular Degeneration
Researchers
- Associate Professor Riccardo Natoli Natoli (Primary Investigator)
- Professor Jan Provis (Secondary Investigator)
- Dr Matt Rutar (Secondary Investigator)
- Mr Kartik Saxena (Secondary Investigator)
Grant status
CompletedGrant start date
01/05/2015Grant funding
- 2015: $6,453 from Thermo Fisher Scientific Inc
